Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.008 | 0.9 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |